Role of Peroxisome Proliferator-Activated Receptor-γ and Its Coactivator DRIP 205 in Cellular Responses to CDDO ( RTA-401 ) in Acute Myelogenous Leukemia

Authors' A Departme 2Departme and Cellu Computatio Center, Ho Pharmacol Research Florida; 7D Medicine, and 9Depa Margaret H Note: Sup Research O Correspon Unit 428, M Houston, T 745-5372;

[1]  M. Sporn,et al.  Neuroprotective Effects of the Triterpenoid, CDDO Methyl Amide, a Potent Inducer of Nrf2-Mediated Transcription , 2009, PloS one.

[2]  F. Khuri,et al.  Coupling of endoplasmic reticulum stress to CDDO-Me-induced up-regulation of death receptor 5 via a CHOP-dependent mechanism involving JNK activation. , 2008, Cancer research.

[3]  J. Issa,et al.  PPARgamma-Active triterpenoid CDDO enhances ATRA-induced differentiation in APL , 2007, Cancer biology & therapy.

[4]  R. Roeder,et al.  Alternative Mechanisms by Which Mediator Subunit MED1/TRAP220 Regulates Peroxisome Proliferator-Activated Receptor γ-Stimulated Adipogenesis and Target Gene Expression , 2007, Molecular and Cellular Biology.

[5]  M. Sporn,et al.  CDDO induces granulocytic differentiation of myeloid leukemic blasts through translational up-regulation of p42 CCAAT enhancer binding protein alpha. , 2007, Blood.

[6]  J. Milbrandt,et al.  Abrogation of nuclear receptors Nr4a3 andNr4a1 leads to development of acute myeloid leukemia , 2007, Nature Medicine.

[7]  M. Sporn,et al.  Triterpenoids and rexinoids as multifunctional agents for the prevention and treatment of cancer , 2007, Nature Reviews Cancer.

[8]  N. Hawker,et al.  Regulation of human epidermal keratinocyte differentiation by the vitamin D receptor and its coactivators DRIP205, SRC2, and SRC3. , 2007, The Journal of investigative dermatology.

[9]  N. Hawker,et al.  Differential role of two VDR coactivators, DRIP205 and SRC-3, in keratinocyte proliferation and differentiation , 2007, The Journal of Steroid Biochemistry and Molecular Biology.

[10]  M. Konopleva,et al.  The triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid and its derivatives elicit human lymphoid cell apoptosis through a novel pathway involving the unregulated mitochondrial permeability transition pore. , 2007, Cancer research.

[11]  P. Nowell,et al.  Evidence of myeloid differentiation in non-M3 acute myeloid leukemia treated with the retinoid X receptor agonist bexarotene , 2007, Cancer biology & therapy.

[12]  Patrick Rodriguez,et al.  The mediator complex functions as a coactivator for GATA-1 in erythropoiesis via subunit Med1/TRAP220 , 2006, Proceedings of the National Academy of Sciences.

[13]  G. Mills,et al.  Reverse phase protein array: validation of a novel proteomic technology and utility for analysis of primary leukemia specimens and hematopoietic stem cells , 2006, Molecular Cancer Therapeutics.

[14]  M. Sporn,et al.  The synthetic triterpenoid CDDO-imidazolide induces monocytic differentiation by activating the Smad and ERK signaling pathways in HL60 leukemia cells , 2006, Molecular Cancer Therapeutics.

[15]  M. Sporn,et al.  Potent protection against aflatoxin-induced tumorigenesis through induction of Nrf2-regulated pathways by the triterpenoid 1-[2-cyano-3-,12-dioxooleana-1,9(11)-dien-28-oyl]imidazole. , 2006, Cancer research.

[16]  M. Konopleva,et al.  Synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest in HER2-overexpressing breast cancer cells , 2006, Molecular Cancer Therapeutics.

[17]  M. Konopleva,et al.  A Novel Mechanism of Action of Methyl-2-cyano-3,12 Dioxoolean-1,9 Diene-28-oate: Direct Permeabilization of the Inner Mitochondrial Membrane to Inhibit Electron Transport and Induce Apoptosis , 2005, Molecular Pharmacology.

[18]  R. Roeder,et al.  The role of transcriptional coactivator TRAP220 in myelomonocytic differentiation , 2005, Genes to cells : devoted to molecular & cellular mechanisms.

[19]  M. Sporn,et al.  2-Cyano-3,12-dioxooleana-1,9-dien-28-imidazolide (CDDO-Im) Directly Targets Mitochondrial Glutathione to Induce Apoptosis in Pancreatic Cancer* , 2005, Journal of Biological Chemistry.

[20]  M. Konopleva,et al.  2-Cyano-3,12-dioxoolean-1,9-dien-28-oic Acid and Related Compounds Inhibit Growth of Colon Cancer Cells through Peroxisome Proliferator-Activated Receptor γ-Dependent and -Independent Pathways , 2005, Molecular Pharmacology.

[21]  Paul Talalay,et al.  Extremely potent triterpenoid inducers of the phase 2 response: correlations of protection against oxidant and inflammatory stress. , 2005, Proceedings of the National Academy of Sciences of the United States of America.

[22]  S. Safe,et al.  Vitamin D-interacting Protein 205 (DRIP205) Coactivation of Estrogen Receptor α (ERα) Involves Multiple Domains of Both Proteins* , 2004, Journal of Biological Chemistry.

[23]  J. Hong,et al.  Peroxisome proliferator-activated receptor gamma-dependent activation of p21 in Panc-28 pancreatic cancer cells involves Sp1 and Sp4 proteins. , 2004, Endocrinology.

[24]  M. Sporn,et al.  The Synthetic Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic Acid Induces Caspase-Dependent and -Independent Apoptosis in Acute Myelogenous Leukemia , 2004, Cancer Research.

[25]  M. Sporn,et al.  c-Jun NH2-Terminal Kinase-Mediated Up-regulation of Death Receptor 5 Contributes to Induction of Apoptosis by the Novel Synthetic Triterpenoid Methyl-2-Cyano-3,12-Dioxooleana-1, 9-Dien-28-Oate in Human Lung Cancer Cells , 2004, Cancer Research.

[26]  M. Konopleva,et al.  Peroxisome proliferator-activated receptor gamma and retinoid X receptor ligands are potent inducers of differentiation and apoptosis in leukemias. , 2004, Molecular cancer therapeutics.

[27]  S. Safe,et al.  A new class of peroxisome proliferator-activated receptor γ (PPARγ) agonists that inhibit growth of breast cancer cells: 1,1-Bis(3′-indolyl)-1-(p-substituted phenyl)methanes , 2004, Molecular Cancer Therapeutics.

[28]  M. Sporn,et al.  Synthetic triterpenoids activate a pathway for apoptosis in AML cells involving downregulation of FLIP and sensitization to TRAIL , 2003, Leukemia.

[29]  D. Gold,et al.  Activation of peroxisome proliferator-activated receptor gamma by a novel synthetic triterpenoid 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid induces growth arrest and apoptosis in breast cancer cells. , 2003, Cancer research.

[30]  O. Coqueret,et al.  New roles for p21 and p27 cell-cycle inhibitors: a function for each cell compartment? , 2003, Trends in cell biology.

[31]  A. Moustakas,et al.  The role of Sp1 family members, the proximal GC-rich motifs, and the upstream enhancer region in the regulation of the human cell cycle inhibitor p21WAF-1/Cip1 gene promoter. , 2002, Biochemistry.

[32]  M. Sporn,et al.  The triterpenoid CDDO induces apoptosis in refractory CLL B cells. , 2002, Blood.

[33]  M. Konopleva,et al.  Role of peroxisome proliferator-activated receptor-gamma in hematologic malignancies. , 2002, Current opinion in hematology.

[34]  M. Sporn,et al.  Chemoprevention: an essential approach to controlling cancer , 2002, Nature Reviews Cancer.

[35]  Yang Li,et al.  T0070907, a Selective Ligand for Peroxisome Proliferator-activated Receptor γ, Functions as an Antagonist of Biochemical and Cellular Activities* , 2002, The Journal of Biological Chemistry.

[36]  M. Sporn,et al.  The Novel Triterpenoid 2-Cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO) Potently Enhances Apoptosis Induced by Tumor Necrosis Factor in Human Leukemia Cells* , 2002, The Journal of Biological Chemistry.

[37]  Tadashi Honda,et al.  Novel triterpenoid CDDO-Me is a potent inducer of apoptosis and differentiation in acute myelogenous leukemia. , 2002, Blood.

[38]  E. Estey,et al.  Therapeutic targeting of the MEK/MAPK signal transduction module in acute myeloid leukemia. , 2001, The Journal of clinical investigation.

[39]  L. Freedman,et al.  Discrete Roles for Peroxisome Proliferator-Activated Receptor γ and Retinoid X Receptor in Recruiting Nuclear Receptor Coactivators , 2000, Molecular and Cellular Biology.

[40]  M. Sporn,et al.  A synthetic triterpenoid, 2-cyano-3,12-dioxooleana-1,9-dien-28-oic acid (CDDO), is a ligand for the peroxisome proliferator-activated receptor gamma. , 2000, Molecular endocrinology.

[41]  L. Freedman,et al.  Functional Interactions between the Estrogen Receptor and DRIP205, a Subunit of the Heteromeric DRIP Coactivator Complex* , 2000, The Journal of Biological Chemistry.

[42]  M. Sporn,et al.  The novel triterpenoid 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid induces apoptosis of human myeloid leukemia cells by a caspase-8-dependent mechanism. , 2000, Cell growth & differentiation : the molecular biology journal of the American Association for Cancer Research.

[43]  M. Lazar,et al.  The DRIP Complex and SRC-1/p160 Coactivators Share Similar Nuclear Receptor Binding Determinants but Constitute Functionally Distinct Complexes , 2000, Molecular and Cellular Biology.

[44]  R. Espinosa,et al.  Amplification and overexpression of peroxisome proliferator-activated receptor binding protein (PBP/PPARBP) gene in breast cancer. , 1999, Proceedings of the National Academy of Sciences of the United States of America.

[45]  K. Umesono,et al.  A Unified Nomenclature System for the Nuclear Receptor Superfamily , 1999, Cell.

[46]  M. Sporn,et al.  A novel synthetic oleanane triterpenoid, 2-cyano-3,12-dioxoolean-1,9-dien-28-oic acid, with potent differentiating, antiproliferative, and anti-inflammatory activity. , 1999, Cancer research.

[47]  J. Auwerx,et al.  The Organization, Promoter Analysis, and Expression of the Human PPARγ Gene* , 1997, The Journal of Biological Chemistry.